Business Wire12 天
Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today ...